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Abstract The mechanism of cell death induced by West Nile
virus (WNV), a causative agent of human febrile syndrome and
encephalitis, was investigated. WNV-infected K562 and Neuro-
2a cells manifested the typical features of apoptosis, including
cell shrinkage, chromatin condensation and subdiploid DNA
content by flow cytometry. DNA fragmentation into nucleosomal
size and changes in outer cell membrane phospholipid composi-
tion were also observed in K562 cells. UV-inactivated virus failed
to induce the above-mentioned characteristics, suggesting that
viral replication may be required for the induction of apoptosis by
WNV. Additionally, signals involved in WNV-induced apoptosis
are associated with the up-regulation of bax gene ex-
pression. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
West Nile virus (WNV), an arthropod-borne, positive-
stranded and enveloped RNA virus, is a member of the genus
£avivirus of the family Flaviviridae. It belongs to the Japanese
encephalitis antigenic complex which includes Kunjin, Murray
Valley encephalitis, Saint Louis encephalitis and Japanese en-
cephalitis viruses [1]. Birds are natural hosts for WNV and
serve as a reservoir from which vector mosquitoes may infect
humans and other mammals [1^10]. A possible airborne route
of infection has also been proposed for many of the labora-
tory infections occurring in persons working with arboviruses
[11]. The Culex species appear to be the primary vector for
WNV [4,7,8] although recently this virus was also detected in
some Aedes and one Anopheles species [12]. The virus is prev-
alent in Africa and the Middle East region and is the causa-
tive agent of the disease syndrome known as West Nile fever.
Encephalitis is a common complication of West Nile fever,
resulting in fatal neurologic disease [1^3,8,13^15]. Recently,
an outbreak of WNV occurred in the northeastern USA fo-
cused in the New York city area. The outbreak resulted in
cases of fatal encephalitis in humans, birds and equines [4^
8,10,12,15,16].
WNV can multiply in the cytoplasm of several cultured cells
showing a cytopathic e¡ect [1,17,18]. Apoptosis is an active
and highly conserved process of cellular self-destruction with
distinctive morphological and biochemical features. It is im-
portant for normal development, host defense and the sup-
pression of oncogenesis [19^21]. Apoptosis is characterized by
a reduction in cell volume, membrane blebbing, chromatin
condensation and endonuclease cleavage of DNA into oligo-
nucleosomal length fragments. Another feature of apoptosis is
the change in the lipid composition of the outer cell mem-
brane, which appears to be important in eliciting a phagocytic
response [20^22]. A number of stimuli can provoke pro-
grammed cell death including viral gene products [20,21,23^
25], and there is a large amount of evidence indicating that
apoptosis is an e⁄cient mechanism by which viruses can cause
death of host cells [26^29]. Conversely, it has been proposed
that apoptosis may support viral progeny dissemination while
limiting induction of in£ammatory and immune responses
[25].
The pathways for the induction of apoptosis are very com-
plex and still unclear in many aspects. The bcl-2 gene family
plays an important role in both positive and negative regula-
tion of programmed cell death [20,30^32]. Bcl-2 was the ¢rst
gene shown to be involved in the regulation of apoptosis [33],
it has proved to be unique among proto-oncogenes in block-
ing programmed cell death rather than promoting cell prolif-
eration [34]. The human bax gene encodes a protein that binds
the Bcl-2 protein and acts in opposition to it [35]. In vivo, bax
is expressed more widely than bcl-2 in cell types that show a
high rate of apoptosis [36]. The ratio of bcl-2/bax determines
the death or survival response to an apoptotic stimulus [34].
The bcl-x gene was identi¢ed due to its similarity to the bcl-2
gene. Bcl-xL, the larger protein product of this gene, renders
cells resistant to apoptosis upon growth factor deprivation,
while Bcl-xs, a shorter alternatively spliced protein, can inhibit
the ability of Bcl-2 to prevent apoptotic cell death [30].
In the present study, we investigated whether apoptosis
contributes to the death of cultured cells infected by WNV.
We demonstrated several characteristics of apoptosis in
WNV-infected cells and showed that viral replication may
be required for the induction of apoptosis. We also provide
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Abbreviations: WNV, West Nile virus; E-MEM, Eagle’s minimum
essential medium; FCS, fetal calf serum; PBS, phosphate-bu¡ered
saline; pi, post-infection; m.o.i., multiplicity of infection; PS, phos-
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results suggesting that bax gene expression is involved in
WNV-induced cell death. These ¢ndings are important be-
cause to our knowledge this is the ¢rst report suggesting
that WNV induces cell death by apoptosis.
2. Materials and methods
2.1. Cell culture and viruses
WNV strain Eg101 was propagated in the C6/36 Aedes albopticus
cell line [37] at 28‡C in Eagle’s minimum essential medium (E-MEM)
supplemented with 2% fetal calf serum (FCS) and non-essential amino
acids (0.1^0.2 mM). Virus titration was done by focus formation assay
using the BHK-21 cell line. Brie£y, cells grown in a monolayer were
infected with the appropriate dilution of virus stock and overlaid with
0.5% methyl cellulose in maintenance medium (2UE-MEM). After
incubation for 72 h, cells were ¢xed with 5% formaldehyde, permea-
bilized with 1% Nonidet-P40 in phosphate-bu¡ered saline (PBS), and
foci of virus-infected cells were visualized by immunoperoxidase stain-
ing.
Inactivated WNV was produced by heating at 56‡C for 40 min or
by UV exposure (254 nm) for 20 min at a distance of 5 cm as pre-
viously described [38]. The loss of infectivity was con¢rmed by the loss
of infectivity to C6/36 cells as well as by attempts to rescue infectious
virus.
The K562 cell line (ATCC number CCL-243) [39], a human mono-
nuclear cell line derived from a patient with chronic myeloid leukemia,
supports £avivirus growth very well [40]. These cells were grown in
RPMI 1640 medium (Gibco BRL) supplemented with 10% FCS at
37‡C in a 5% CO2 atmosphere. The Neuro 2a (N2a) cell line (ATCC
number CCL-131) is a mouse neuroblastoma cell line that also sup-
ports £avivirus growth [41]. This cell line was grown under the same
conditions as K562 but using E-MEM medium.
For virus infection, 5U105 or 1U106 cells were adsorbed with
virus, at a multiplicity of infection (m.o.i.) of 1 for 2 h. Then, non-
adsorbed virus was removed and RPMI 1640 or E-MEM medium
containing 2% FCS was added. The cells were then incubated at
37‡C for various time periods.
2.2. Cell viability assay
Cell viability was determined by the trypan blue exclusion test. Cells
were harvested at di¡erent intervals post-infection (pi), resuspended in
PBS and mixed with an equal volume of 0.1% trypan blue. The cells
that excluded the dye were counted under a microscope using a hemo-
cytometer chamber.
2.3. Viral antigen detection
Virus- and mock-infected cells were harvested at 24, 48 or 72 hpi,
¢xed with 2% formaldehyde in PBS and permeabilized with IC-
Perm1 (cell permeabilization bu¡er, Biosource International, Tokyo,
Japan). Viral antigen was detected by £ow cytometry using a FITC-
labeled anti-£avivirus group-speci¢c monoclonal antibody (FITC-
6b6c-1) [42]. The green £uorescence of individual cells was measured
using a FacScan £ow cytometer (Becton Dickinson). The analysis of
green £uorescence-positive cells was performed with 10 000 events
from each sample.
2.4. Nuclear Hoechst staining
Chromatin condensation, a characteristic of cells undergoing apo-
ptosis [20,21], was visualized by Hoechst staining [43]. The Hoechst
dye is membrane-permeant and thus labels the nuclei of both living
and dead cells. WNV- and mock-infected cells were harvested at 24 or
72 hpi. The cells were washed once with PBS and treated with 10 Wg/
ml Hoechst 33258 (Sigma) in PBS at 37‡C for 5 min. The cells were
then washed with PBS and examined under a £uorescence microscope
(Zeiss, Axiovert 135M).
2.5. Annexin V staining
The redistribution of phosphatidylserine (PS) from the inner to the
outer layer of the cell membrane of apoptotic cells can be detected
using the phospholipid binding protein annexin V [44]. In this study,
the Annexin V-cy 3 Apoptosis Detection Kit (Medical and Biological
Laboratories Co., Nagoya City, Japan) was used and the proportion
of positive cells was counted using a £uorescence microscope (Zeiss,
Axiovert 135M).
2.6. DNA fragmentation by ladder analysis
Fragmentation of cellular DNA into characteristic apoptotic lad-
ders was assessed using the method previously published by Park and
Patek [45].
2.7. Propidium iodide (PI) staining
The staining of the isolated nuclei was done as previously published
[46]. Virus-inoculated cells were harvested at 24, 48 or 72 hpi. The PI
£uorescence of individual nuclei was measured using a FacScan £ow
cytometer (Becton Dickinson) and 10 000 events were collected for
each sample. A reduced cellular DNA content due to fractioning of
the apoptotic cells and formation of apoptotic bodies is a character-
istic feature of cells undergoing apoptosis [21]. This e¡ect leads to the
occurrence of a sub-G1 cell population containing cells with lower
DNA content compared to cells in the G1 phase of the cell cycle.
2.8. RNA extraction and cDNA synthesis
Total RNA preparations from 3U105 or 6U105 uninfected cells
and cells infected with WNV were obtained by the guanidine isothio-
cyanate method using TRIzol (Gibco BRL) [47] according to the
manufacturer’s instructions. Possible contamination with genomic
DNA was eliminated by treating the extract of RNA with DNase I
enzyme. To assess mRNA expression, a reverse transcription-poly-
merase chain reaction (RT-PCR) method was used. For the RT re-
action, total RNA was primed with hexanucleotide random primers
(TaKaRa) and reverse-transcribed with SuperScript1 II reverse tran-
scriptase (Gibco BRL) in a 20 Wl reaction.
2.9. Real-time PCR quanti¢cation
2.9.1. Ampli¢cation. The newly synthesized cDNA was subjected
to ampli¢cation using the Light cycler-DNA Master SYBR Green I
Kit (Roche Molecular Biochemicals) for real-time PCR analysis, fol-
lowing the manufacturer’s instructions. SYBR Green I is a DNA
double-strand-speci¢c dye. As DNA is synthesized, SYBR Green I
binds to the ampli¢ed PCR product and the increase in amplicon
concentration can be quanti¢ed by its £uorescence. Ampli¢cation
was performed in glass capillaries in a 20 Wl reaction mixture contain-
ing 1USYBR Green I Master Mix, 0.5 pmol of forward and reverse
primers (5P-CGGGCATTCAGTGACCTGAC-3P and 5P-TCAGGAA-
CCAGCGGTTGAAG-3P [48] for the human bcl-x gene; 5P-CTGAC-
GGCAACTTCAACTGG-3P and 5P-TCTTGGATCCAGCCCAA-
CAG-3P [49] for the bax gene; 5P-GCTGCACCTGACGCCCTTCA-
3P and 5P-CTTCAGAGACAGCCAGGAGA-3P for the bcl-2 gene; 5P-
CATGAAGTGTGACGTGGACATCC-3P and 5P-GCTGATCCAC-
ATCTGCTGGAAGG-3P for the L-actin gene), 4 mM of MgCl2,
and target cDNA (2 Wl for the detection of the apoptosis-regulating
genes and 1 Wl for the detection of the L-actin gene). The L-actin gene
was used as an internal control for the expression of the three former
genes. The generated PCR products were 340, 160, 301 and 229 bp
long for the bcl-xL, bax, bcl-2 and L-actin genes, respectively. Con-
ditions for cycling were 95‡C for 30 s, followed by 40 cycles of 0 s at
95‡C (short denaturation), 5 s at 58‡C and 16 s at 72‡C. Ampli¢cation
and detection were performed with the Light Cycler instrument
(Roche Diagnostics). A negative control was included in each run
and speci¢city of ampli¢cation reactions was checked by melting
curve analysis [50].
2.9.2. Data analysis. PCR data were obtained by considering the
log-linear portion of the £uorescence curve. Analysis of raw data was
done with the Light Cycler software version 3.0 (Roche Diagnostics).
A standard curve for each PCR product was calculated automatically
by plotting the threshold cycle values against each standard of known
concentration in picogram quantities and calculation of the linear
regression line of this curve. All standard curves had a correlation
coe⁄cient of 1 and mean square error (E) 6 0.2. The experimentally
determined standard curve was, in turn, used to estimate the concen-
tration of each sample.
3. Results
3.1. Infection of K562 and N2a cells by WNV
WNV-infected cells expresses viral antigens in their cyto-
plasm [1]. FITC-labeled anti-£avivirus group-speci¢c mono-
clonal antibody was used to detect viral protein, and the
number of infected cells was quantitated by £ow cytometry.
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About 68% of the K562 cells were infected at 24 h after in-
oculation at a m.o.i. of 1, and almost all cells were infected
after 48 h of inoculation (90%) (Fig. 1). Fifteen percent of the
N2a cells were infected with WNV at 24 hpi and the peak
(65%) was observed at 48 hpi (Fig. 1). No £uorescence was
detected for either cell line at any of the times pi when inoc-
ulated with heat or UV-inactivated WNV. Similarly, controls
with FITC-labeled normal IgG2a antibody yielded negative
results with both WNV-infected and uninfected cells (data
not shown).
3.2. Cell viability
At 24 hpi, K562 cells infected with WNV started to exhibit
some cytopathic changes such as membrane blebbing and cell
shrinkage. Such changes were much increased at 72 hpi (Fig.
2A). N2a cells exhibited similar cytopathic changes, rounding
of the cells, detachment from the monolayer and cell shrink-
age.
The trypan blue exclusion test revealed that the decrease in
viable cells was time-dependent. Ninety-three percent, 79%
and 24% of K562 cells remained viable after infection with
WNV for 24, 48 and 72 hpi, respectively, whereas less than
4% of mock-infected cells were permeable to the dye at 72 hpi
(Fig. 2B). WNV-infected N2a cells showed similar results with
the percentage of viable cells decreasing from 94% to 48% at
24 and 72 hpi, respectively. However, for mock-infected cells a
much lower degree of cell mortality was observed (less than
4% throughout the experiment).
3.3. Apoptosis of WNV-infected cells
In searching for the characteristic features of apoptotic cell
death three methodologies were used in this study. Mock- and
virus-infected K562 cells were harvested at di¡erent times pi.
In the ¢rst method, cellular DNA was isolated, run on 2%
agarose gels and tested for the presence of characteristic DNA
fragmentation. DNA laddering with increments of 180^200 bp
in size was barely noticeable at 24 hpi but became evident at
72 hpi (Fig. 3). No such DNA ladders were observed for
mock-infected cells. To support this ¢nding, nuclear staining
was carried out to check for cellular damage using the
Hoechst staining method. At 24 hpi almost 13% of the nuclei
of the WNV-inoculated K562 cells were irregularly shaped,
Fig. 1. Kinetics of WNV infection in K562 and N2a cells. WNV-in-
fected K562 and N2a cells were harvested at di¡erent times pi. The
¢xed and permeabilized cells were treated with FITC-labeled anti-
£avivirus group-speci¢c monoclonal antibodies [41] and analyzed by
£ow cytometry. A data set representative of three experiments is
shown. WN and m indicate WNV- and mock-infected cells, respec-
tively.
Fig. 2. Cell death by WNV infection. K562 and N2a cells were in-
fected by WNV (m.o.i. = 1). A: Photographs of WNV-infected K562
(1) and N2a (3) cells, and mock-infected K562 (2) and N2a (4) cells
at 72 h after infection (18U magni¢cation). WNV-infected cells ex-
hibited cytopathic changes such as rounding of the cells, detachment
from the monolayer and cell shrinkage. B: The number of viable
cells was counted by the trypan blue exclusion test at the indicated
times pi. A data set representative of three experiments is shown.
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and the percentage rose markedly to 87% by 72 hpi (Fig. 4).
Internally segmented nuclei were evident in some cells, as a
typical feature of cells undergoing apoptosis on viral infection.
On the other hand, under the £uorescence microscope the vast
majority of mock-infected cells showed normal round nuclei
with evenly distributed chromatin even at 72 hpi. Only a little
over 2% of these cells showed irregularly shaped nuclei.
The relocation of PS to the outer layer of the cell membrane
was detected by the use of annexin V [22,44] (Fig. 5). The
number of annexin V-positive cells was signi¢cantly elevated
in infected cells. The values at 24 and 72 hpi were 10% and
68% for WNV-infected cells, and 2% and 3% for mock-in-
fected cells, respectively.
To quantify apoptotic cells, K562 and N2a cells were inoc-
ulated with either WNV or inactivated WNV or were mock-
infected. The cells were then analyzed by £ow cytometry using
DNA staining with PI [46] (Fig. 6a). The proportion of cells
showing subdiploid DNA content increased with time after
infection. WNV-inoculated K562 cells manifested a signi¢cant
reduction in the percentage of nuclei with diploid DNA con-
tent, while the hypodiploid DNA peak was greatly enhanced
from 4.8% at 24 hpi to 52% at 72 hpi (Fig. 6b). Conversely,
the proportion of mock-infected cells with subgenomic DNA
content was 3% at 72 hpi. Likewise, infected N2a cells showed
an increase in the percentage of cells with subdiploid DNA
content with the progression of time. At 48 and 72 hpi, 7%
and 37% of cells were apoptotic, respectively. On the other
hand, only a very small proportion of mock-infected N2a cells
showed signs of apoptosis even at 72 hpi (Fig. 6c). Cells in-
fected with heat-inactivated WNV, used as a second negative
control, did not show a signi¢cant level of apoptosis (less than
5% at 72 hpi, data not shown).
In order to determine whether WNV-induced apoptosis is
triggered by the attachment of virions to the cell membrane or
by signals originating from within the infected cells, cultured
K562 and N2a cells were inoculated with UV-inactivated
WNV. The inoculated cells were not stained when speci¢c
antiserum was used in immuno£uorescence and no infectious
focus was detected by focus-forming assay (data not shown).
Accordingly, UV-inactivated virus failed to induce apoptosis
in inoculated cells judging by the low percentage of cells with
subdiploid DNA content at 72 hpi (Fig. 6b,c).
3.4. WNV-induced apoptosis is associated with upregulation of
bax mRNA
To investigate the mechanism by which WNV induced ap-
optosis in K562 and N2a cells, the levels of expression of bcl-2
family members were determined. For N2a cells, bcl-2 and
bax gene expression was measured. Otherwise, for K562 cells,
the expression of bcl-xL and bax mRNA was measured in-
Fig. 3. Oligonucleosomal DNA fragmentation induced by WNV in-
fection. DNA was extracted from mock-infected and WNV-infected
K562 cells (m.o.i. = 1) at 24 and 72 hpi using the method proposed
by Park and Patek [44]. The samples were analyzed by electrophore-
sis on a 2% agarose gel and stained with ethidium bromide. Lane
M contains a 100-bp DNA ladder used as a marker. Internucleoso-
mal DNA cleavage in infected cells was barely noticeable at 24 hpi
but became evident at 72 hpi. No such DNA ladders were seen in
mock-infected cells.
Fig. 4. Nuclear staining of apoptotic cells. K562 cells were infected
by WNV (m.o.i. = 1) and harvested at di¡erent times pi and treated
with Hoechst 33258 in PBS. A data set representative of two experi-
ments is shown.
Fig. 5. Visualization of the change in the lipid composition of the
outer cell membrane of apoptotic cells. K562 cells were infected by
WNV (m.o.i. = 1), harvested at di¡erent times after infection and
treated with Annexin V-cy 3. A data set representative of two ex-
periments is shown.
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stead. This was because K562 cells do not express the bcl-2
gene [48]. Expression of apoptosis-related genes was tested in
lysates of mock-infected and WNV-infected cells harvested at
0 and 6 hpi, using a quantitative RT-PCR (Fig. 7a,b). For
K562 cells, the expression of bcl-xL mRNA did not change in
WNV-infected cells (7.1U1034 pg), however bax mRNA lev-
els were markedly elevated (from 8.9U1035 pg to 1U1033 pg)
at 6 h after inoculation. In contrast, the expression of bcl-xL
(4^5U1034 pg) and bax (3.5U1034 pg) mRNA was not af-
fected in mock-infected cells. The ratios bcl-xL/bax were 7.98
and 0.71 for WNV-infected K562 cells at 0 and 6 hpi, respec-
tively. For N2a cells, the levels of bax mRNA were also ele-
vated (from 1U1033 pg to 4.5U1033 pg) at 6 h after inocu-
lation when infected with WNV. Otherwise, for mock-infected
cells the expression of this gene remained unchanged (6U1034
pg). The bcl-2 gene expression for both mock- and WNV-
Fig. 6. Subdiploid DNA content determination for the detection of
apoptotic cells. Cells were infected with WNV (m.o.i. = 1) and i-
WNV (UV-inactivated WNV), while the control cells were mock-in-
fected. They were harvested at various intervals pi. Cell pellets were
resuspended in 1 ml of hypotonic £uorochrome solution as previ-
ously described [45]. The PI £uorescence of individual nuclei was
measured by £ow cytometry. Ten thousand events were collected
from each sample. a: Illustration of a typical histogram plot. Cells
with lower DNA content (sub-G1) appear on the left side of cells
with diploid DNA content, showing a lower PI intake. Data sets
for K562 (b) and N2a (c) cells representatives of four and three ex-
periments, respectively, are shown.
Fig. 7. Gene expression in WNV-infected apoptotic cells. Total
RNA was extracted from mock- and WNV-infected cells at 0 and 6
hpi. cDNA was synthesized and real-time PCR was performed to
quantify the expression of bcl-2, bcl-xL and bax genes. As an inter-
nal control, the gene expression of L-actin was also measured. The
results plotted were estimated using an experimentally determined
standard curve and represent one data set of two experiments.
a: K562 cells. b: N2a cells. 8, L-actin; F, bax; R, bcl-xL ; and b,
bcl-2 gene expression in WNV-infected cells ; 7, L-actin; E, bax;
O, bcl-xL ; and a, bcl-2 gene expression in mock-infected cells. The
y-axis shows the log10 of the concentration in picograms and the
x-axis shows the time in hours.
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infected N2a cells showed a slight decrease at the two times
considered (from 3.5U1033 pg to 1.8U1033 pg for the mock-
infected and from 5U1033 pg to 2U1033 pg for the WNV-
infected). The ratios bcl-2/bax were 3.50 and 0.40 for WNV-
infected N2a cells at 0 and 6 hpi, respectively. As a control,
the level of L-actin mRNA remained unchanged throughout
the course of viral infection.
4. Discussion
Comprehension of the mechanisms by which viruses induce
cell death is important in our understanding of the pathogen-
esis of viral infections. To our knowledge this is the ¢rst re-
port demonstrating that the cytopathic e¡ect of WNV infec-
tion is mediated by the induction of apoptosis. Cell shrinkage
and the appearance of DNA fragmentation were observed in
WNV-infected but not in mock-infected cells. FacScan anal-
ysis revealed that the number of apoptotic cells increased with
time. These data are also consistent with results obtained for
Hoechst 33258 staining and annexin V binding of PS in K562
cells. The observation of a combination of typical morpho-
logical and biochemical characteristics of apoptosis allows us
to conclude that apoptotic cell death is important in establish-
ing a pathogenic role in this model of virus infection. Cardoso
et al. [38] reported that UV-inactivated measles virus retains
its capacity to bind cells and to fuse with the plasma mem-
brane delivering its nucleoprotein into the cytosol to be pro-
cessed for antigen presentation. Hence, the same conditions
were applied for inactivation of WNV. The observation that
UV-inactivated WNV failed to induce apoptosis suggests that
active viral replication might be necessary for the induction of
apoptosis by WNV. These ¢ndings indicate that, in this mod-
el, apoptosis might not be induced only by the attachment or
penetration of viral particles into the host cell.
The bcl-2 family includes a series of homologous genes,
which include bcl-2, bax, bcl-xL, bcl-xs and bad, all of which
are important intracellular regulators of programmed cell
death [20,32,51]. These genes are involved in di¡erent path-
ways of induction or repression of apoptosis. Usually bcl-2
and bcl-xL inhibit apoptosis [20,34,48,52^54] while bax, bad
and bcl-xs induce apoptotic cell death [20,35,36,55,56]. En-
forced expression of Bcl-2 or Bcl-xL proteins has been re-
ported to block apoptosis induced by various stimuli [57],
including viruses such as alphavirus vectors [58], Japanese
encephalitis virus [59], La Crosse virus [60], Sindbis virus
[31], resulting in prolonged cell survival. Conversely, another
cellular protein, Bax, was reported to be widely expressed in
various cell types showing high rates of apoptosis [36]. In this
study, the mechanism by which WNV induces apoptosis in
infected K562 and N2a cells was investigated. K562 cells do
not express the bcl-2 gene [48] or they do so at very low levels
[56], in spite of showing resistance to many chemotherapeutic
agents and radiation [61]. Therefore, the expression of the bcl-
xL and bax genes was investigated in WNV-infected and in
mock-infected K562 cells. The expression of the pro-apoptotic
bax gene showed an 11-fold increase within 6 h of infection,
while the level of the anti-apoptotic bcl-xL gene was unaf-
fected. For the mock-infected cells, the expression of both
genes remained at the same levels. WNV-infected N2a cells
also showed an increase in bax mRNA levels (4.5 times) 6 hpi
while mock-infected cells did not. The levels of bcl-2 mRNA
slightly decreased in both mock- and virus-infected cells. The
lower increment of bax gene expression shown by N2a cells
may explain the lower degree of apoptosis noted for this cell
line at 72 hpi (37% vs. 52% for K562 cells). These results
suggest that the bax gene was speci¢cally upregulated by
WNV infection and that it might be involved in the induction
of apoptosis in WNV-infected K562 and N2a cells. We can
thus hypothesize that the increased expression of bax is one of
the mechanisms responsible for WNV-induced apoptosis.
Similar ¢ndings were reported by Kobayashi et al. [56], who
using a gene transfer system to modulate bax gene expression
demonstrated that overexpression of this gene can predispose
K562 cells to apoptosis induced by a wide range of chemo-
therapeutic agents.
It has been known that the bcl-2 family of genes forms
homodimers and heterodimers [20]. For example, bcl-2 and
bcl-xL form homodimers and heterodimerize with bcl-xs,
bax, bad, Mcl-1, and also with each other [62^65]. It has
also been proposed that the bcl-2/bax ratio in a cell acts as
a rheostat that regulates susceptibility to apoptosis [34]. This
rheostat may be directed towards the development of apopto-
sis by repressing bcl-2 and promoting bax expression
[35,66,67]. Similarly, as bcl-xL, but not bcl-2, is expressed in
K562 cells, we can speculate that the bcl-xL/bax ratio may act
as a rheostat as well. In this report, the level of bax gene
expression was upregulated in WNV-infected K562 and N2a
cells at 6 hpi while the expression of bcl-xL and bcl-2 was
unchanged or slightly decreased. The ratio bcl-2/bax for
WNV-infected N2a cells decreased almost nine times within
6 h of infection while only a two-fold decrease was observed
for mock-infected cells. In addition, whereas the bcl-xL/bax
ratio decreased 11-fold for WNV-infected K562 cells it re-
mained unchanged for mock-infected cells. Therefore, an im-
balance in the relative proportion of these apoptosis-regulat-
ing genes could be responsible for the WNV-induced
apoptotic cell death observed in the two cell lines considered.
Similarly, recent results published by Gallaher et al. [68] on
the expression of apoptosis genes in cells treated with colce-
mid concluded that, considering the ratio of RT-PCR den-
sities, in either of the cell lines tested, the level of apoptosis
correlated better with the bcl-xL/bax ratio than with the bcl-2/
bax ratio.
WNV is the causative agent of West Nile fever and en-
cephalitis is a common complication that may result in fatal
neurologic disease mainly involving damage to neurons of
the brainstem [8]. Immunostains of tissues from several birds
collected during the outbreak of WNV that occurred in the
northeastern USA in 1999 revealed that the brains of most
birds were infected with this virus and that WNV antigen was
also present in the neurons of the brainstem [5]. In addition,
WNV was found to infect mainly neurons in cultures of spinal
cord slices, a model for studying the pathogenicity of neuro-
tropic viruses [18]. Moreover, it was also recently reported
that apoptotic cell death is an important cause of neuronal
injury in experimental viral infection in vivo [27,69,70]. Our
study shows that WNV infection of the N2a cells resulted in
cell death by apoptosis, judging from the increase in the pro-
portion of cells showing subdiploid DNA content (Fig. 6c).
Therefore, it is possible that apoptosis may represent a patho-
genic mechanism of this virus.
Several viral proteins has been shown to contribute to the
induction of apoptosis [71^74]. Determining whether any
WNV protein per se is able to induce apoptosis or if the
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process is initiated by the release of soluble factors, such as
cytokines, from WNV-infected cells requires further investiga-
tion.
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